Background Accurate routine HIV viral load testing is essential for assessing the efficacy of
antiretroviral treatment (ART) regimens and the emergence of drug resistance. While the use …

Background Dried blood spots (DBS) have been used as alternative specimens to plasma to
increase access to HIV viral load (VL) monitoring and early infant diagnosis (EID) in remote …

There are inefficiencies in current approaches to monitoring patients on antiretroviral
therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical …

Objective: To assess technical and operational performance of a dried blood spot (DBS)-
based HIV-1 RNA service for remote healthcare facilities in a low-income country. Design: A …

Dried blood spots (DBS) can be used in developing countries to alleviate the logistic
constraints of using blood plasma specimens for viral load (VL) and HIV drug resistance …

Objectives Dried blood spots (DBS) and dried plasma spots (DPS) are easy to collect and
store, and have been successfully tested as an alternative to plasma for performing …

By the end of 2008, 4 million people were receiving antiretroviral treatment for HIV/AIDS in
low-and middle-income countries. In industrialized countries, monitoring of treatment with …

Background HIV RNA suppression is a key indicator for monitoring success of antiretroviral
therapy. From a logistical perspective, viral load (VL) testing using Dried Blood Spots (DBS) …

Abstract World Health Organization-recommended surveys of acquired HIV-1 drug
resistance include assessment of HIV-1 viral load suppression to levels below 1,000 …

Background Routine HIV viral load testing is not widely accessible in most resource-limited
settings, including Kenya. To increase access to viral load testing, alternative sample types …